Wuhan Coronavirus Resource Thread

The Strategic Issues & International Relations Forum is a venue to discuss issues pertaining to India's security environment, her strategic outlook on global affairs and as well as the effect of international relations in the Indian Subcontinent. We request members to kindly stay within the mandate of this forum and keep their exchanges of views, on a civilised level, however vehemently any disagreement may be felt. All feedback regarding forum usage may be sent to the moderators using the Feedback Form or by clicking the Report Post Icon in any objectionable post for proper action. Please note that the views expressed by the Members and Moderators on these discussion boards are that of the individuals only and do not reflect the official policy or view of the Bharat-Rakshak.com Website. Copyright Violation is strictly prohibited and may result in revocation of your posting rights - please read the FAQ for full details. Users must also abide by the Forum Guidelines at all times.
Suraj
Forum Moderator
Posts: 15043
Joined: 20 Jan 2002 12:31

Re: Wuhan Coronavirus Resource Thread

Post by Suraj »

Yeah I know what you mean - there were a lot of vaccinations late Saturday that are not visible in the 7pm report . The reason I prefer the 7pm report is that the 8am report PDF is not easily searchable . If you’ve tried to find an older 8am report you’ll know what I mean - a combination of factors make them not easily searchable on Google .
Mort Walker
BRF Oldie
Posts: 10033
Joined: 31 May 2004 11:31
Location: The rings around Uranus.

Re: Wuhan Coronavirus Resource Thread

Post by Mort Walker »

Also, the MoHFW 8AM morning report has the daily breakdown of 1st and 2nd dose numbers by state or UT. I look at that which is really interesting. Don’t have the time, but if you put the data into a spreadsheet, it becomes apparent which states are steadily progressing.
Kakkaji
BRF Oldie
Posts: 3866
Joined: 23 Oct 2002 11:31

Re: Wuhan Coronavirus Resource Thread

Post by Kakkaji »

48,41,81,676 https://pib.gov.in/PressReleasePage.aspx?PRID=1742032 [03 AUG 2021 7PM Tuesday]
47,78,00,587 https://pib.gov.in/PressReleasePage.aspx?PRID=1741648 [02 AUG 2021 7PM Monday]

Total for 24 hours ending 7pm Tuesday 03 August: 63,81,089 doses

Record more than 22 lakh Vaccine Doses administered in UP today till 7 pm

Cumulative first dose = 37,70,98,591
Cumulative second dose = 10,70,83,085
vijayk
BRF Oldie
Posts: 8785
Joined: 22 Jun 1999 11:31

Re: Wuhan Coronavirus Resource Thread

Post by vijayk »

https://economictimes.indiatimes.com/ne ... 931172.cms

Biological E plans to break into the big league by manufacturing three Covid-19 vaccines
The Datlas of Hyderabad have come a long way. From making anticoagulant heparin injections and creating popular brands like Crocin and Lacto Calamine, the family is on the cusp of breaking into the big league, with the flagship company Biological E (BE) planning to manufacture three Covid-19 vaccines.
Kakkaji
BRF Oldie
Posts: 3866
Joined: 23 Oct 2002 11:31

Re: Wuhan Coronavirus Resource Thread

Post by Kakkaji »

Indian Immunologicals likely to start Covaxin production in a month
Indian Immunologicals (IIL), a public sector enterprise, will start manufacturing and supplying Covid-19 vaccines by the end of August or early September from its facility in Hyderabad. This would augment production of Bharat Biotech’s Covaxin vaccine in the country.

V K Paul, member, health, Niti Aayog, said there was now some visibility about contribution from IIL, with supply of two million doses expected from August-September onwards. The other two public sector companies, Haffkine Biopharmaceutical Corporation in Mumbai and Bharat Immunologicals & Biologicals in Bulandshahar (Uttar Pradesh) were expected to take some more time to start production as they are building infrastructure, which could be ready by November or December.

The government on Tuesday said in the Rajya Sabha that based on information shared by the vaccine makers, the monthly production of Covaxin was projected to go up to 58 million doses, while Serum Institute of India was expected to reach 120 million doses a month. Responding to a question of capacity to manufacture Covaxin and Covishield, Union health minister Mansukh Mandaviya said in a written reply that Covishield’s production capacity was projected to be increased from 110 million doses to more than 120 million doses per month.

Production capacity of Covaxin was projected to go up from 25 million doses per month to around 58 million doses per month. The government had in June launched the Covid Suraksha mission to augment production of Bharat Biotech’s Covaxin by utilising capacity at two central and one state public sector enterprise. Technology transfer was also made to the Gujarat Covid Vaccine Consortium led by Gujarat Biotechnology Research Centre along with Hester Biosciences and OmniBRx Biotechnologies.

Availability of Covaxin had been affected as Bharat Biotech has not been able to ramp up its production capacity. According to Paul, a significant quantity of the vaccines was to come from Bharat Biotech’s new facility at Bengaluru but there have been issues of output, quality assurance, standardisation and optimisation of production, which takes time and has caused a delay in production ramp-up

These issues have now been sorted out and manufacturing had started. Bharat Biotech has also created additional facilities at Ankleshwar where it had a rabies vaccine plant. This plant would make an additional six million units of the Covaxin.


During July 2021, the government supplied 51 crore doses of the Covid-19 vaccine and Paul said the government was hopeful that the road map for August to December would hold good. The government has said it will supply 135 crore vaccines, which are expected to be available between August and December.
chetak
BRF Oldie
Posts: 32283
Joined: 16 May 2008 12:00

Re: Wuhan Coronavirus Resource Thread

Post by chetak »

Within hours of the news that #COVAXIN works the best against the Delta variant, and that a certain vaccine's efficacy is suspect, came several news stories casting aspersions on Covaxin. Totally uncoordinated, totally organic.


pfizhoren company pays the corrupted and sold out presstitute deshdrohis' well


Company's initial Production from New Plant Quality Check is being Propogated by NDTV as Covaxin Quality issue.



Image
Amber G.
BRF Oldie
Posts: 9265
Joined: 17 Dec 2002 12:31
Location: Ohio, USA

Re: Wuhan Coronavirus Resource Thread

Post by Amber G. »

^^^That was shocking, shameful, and dangerous misreporting by ⁦@SreenivasanJain⁩ This is not Journalism one can trust.
How NDTV’s Sreenivasan Jain played mischief to create panic regarding Covaxin efficacy
nandakumar
BRFite
Posts: 1638
Joined: 10 May 2010 13:37

Re: Wuhan Coronavirus Resource Thread

Post by nandakumar »

At the end of the day what matters is not NDTV propaganda but one that addresses the question whether Bharat Biotech is able to sell all that it can produce.
Pratyush
BRF Oldie
Posts: 12195
Joined: 05 Mar 2010 15:13

Re: Wuhan Coronavirus Resource Thread

Post by Pratyush »

Given the demand for vaccines in India itself and the order backlog. I would not worry about the covaxin not being sold. I am concerned about meeting the production requirements for the vaccines.

In terms of production I personally think that we are between 4 to 6 weeks behind where we should have been. That is getting 150 million doses of covidshied and covaxin from mid June to July end.

Consequently our vaccination effort is also lagging behind by that time frame.
Suraj
Forum Moderator
Posts: 15043
Joined: 20 Jan 2002 12:31

Re: Wuhan Coronavirus Resource Thread

Post by Suraj »

Jain is simply putting a negative spin on something that's a mundane occurence in vaccine development - the first batches are test ones and will likely fail QA. When they scale up, they'll also retest their processes to ensure they meet QA requirements.

A real analysis would be one that tries to compare yield rate of different vaccines during their early batches. But that's impossible because no one will reveal that. Instead what you get from this character is cheap hearsay. I looked for the quoted person on Twitter, but he apparently is not on SM. Very convenient for Jain. The man isn't trained to talk about the topic he talks about.

Always make it a point to get information ONLY from the primary source. Never utilize information form the MSM that is paraphrased. Their goal is to remain the privileged intermediaries who provide us the 'information' in the manner that suits them. I ignore all opinion pieces on Indian vaccination - they're not worth the time. Any statement that goes 'XYZ / unnamed source said' is also ignored.
Kakkaji
BRF Oldie
Posts: 3866
Joined: 23 Oct 2002 11:31

Re: Wuhan Coronavirus Resource Thread

Post by Kakkaji »

Amber G. wrote:^^^That was shocking, shameful, and dangerous misreporting by ⁦@SreenivasanJain⁩ This is not Journalism one can trust.
How NDTV’s Sreenivasan Jain played mischief to create panic regarding Covaxin efficacy
Bharat Biotech should sue Sreenivas Jain and NDTV.
fanne
BRF Oldie
Posts: 4282
Joined: 11 Feb 1999 12:31

Re: Wuhan Coronavirus Resource Thread

Post by fanne »

yu Sue them
chetak
BRF Oldie
Posts: 32283
Joined: 16 May 2008 12:00

Re: Wuhan Coronavirus Resource Thread

Post by chetak »

Today, US House Foreign Affairs Committee has released an addendum to the Origins of COVID-19 Report.

Worth reading in full.

https://gop-foreignaffairs.house.gov/wp ... REPORT.pdf





Image
Amber G.
BRF Oldie
Posts: 9265
Joined: 17 Dec 2002 12:31
Location: Ohio, USA

Re: Wuhan Coronavirus Resource Thread

Post by Amber G. »

Kakkaji wrote:
Amber G. wrote:^^^That was shocking, shameful, and dangerous misreporting by ⁦@SreenivasanJain⁩ This is not Journalism one can trust.
How NDTV’s Sreenivasan Jain played mischief to create panic regarding Covaxin efficacy
Bharat Biotech should sue Sreenivas Jain and NDTV.
Bharat Biotech (and other good people) is/are busy doing positive things like making vaccines..while these dishonest reporters are doing REAL damage. Sreenivas Jain/ NDTV has zero excuse for tweeting that dishonest misleading report - which BTW was retweeted thousands of times and picked up by others before NDTV issued the clarification that none of the those vaccines were distributed. By that time enough damage was done and it looked all was as coordinated as those Farmer's protests, or reports of "BJP (=unsafe)" vaccine.

----
Meanwhile here in Ohio (US) just got a text message on my phone - telling me that our county has issued mask mandate (or strong recommendation) for indoors and asking us for *any* help if we need vaccinations . (Our whole family was fully vaccinated way back in March but *many* people still are against masks and vaccinations and other scientific understanding).
chetak
BRF Oldie
Posts: 32283
Joined: 16 May 2008 12:00

Re: Wuhan Coronavirus Resource Thread

Post by chetak »

Amber G. wrote:
Kakkaji wrote:
Bharat Biotech should sue Sreenivas Jain and NDTV.
Bharat Biotech (and other good people) is/are busy doing positive things like making vaccines..while these dishonest reporters are doing REAL damage. Sreenivas Jain/ NDTV has zero excuse for tweeting that dishonest misleading report - which BTW was retweeted thousands of times and picked up by others before NDTV issued the clarification that none of the those vaccines were distributed. By that time enough damage was done and it looked all was as coordinated as those Farmer's protests, or reports of "BJP (=unsafe)" vaccine.

----
Meanwhile here in Ohio (US) just got a text message on my phone - telling me that our county has issued mask mandate (or strong recommendation) for indoors and asking us for *any* help if we need vaccinations . (Our whole family was fully vaccinated way back in March but *many* people still are against masks and vaccinations and other scientific understanding).
Amber G ji,

NDTV is watched abroad and j@in has been benefited to do this by gora competitors and it has been done deliberately with malicious intent.

j@in claims that he deleted the "offending" tweet and so he did but after a calculated delay of more than 10 hours.

Within hours of the news that #COVAXIN works the best against the Delta variant, and that a certain vaccine's efficacy is suspect, came several news stories casting aspersions on Covaxin.

These presstitutes want us to believe that their reportage is totally uncoordinated, totally organic, and it is fearless journalism on their part.

These guys are card carrying members of the Indian media taliban
saip
BRF Oldie
Posts: 4231
Joined: 17 Jan 2003 12:31
Location: USA

Re: Wuhan Coronavirus Resource Thread

Post by saip »

50% of the active cases in India are coming from ONE state - Kerala. They even received and award for management of Covid19. So what happened?
chetak
BRF Oldie
Posts: 32283
Joined: 16 May 2008 12:00

Re: Wuhan Coronavirus Resource Thread

Post by chetak »

meanwhile, back at the ranch....

the ameriki big pharma is still desperately trying to push its way into the Indian market with their quoted high prices and insistence on zero liability for any issues that may affect the Indian customer using their vaccines.

Now they have slyly bundled their vaccines in the "free donation of 80 million doses" of American-made COVID vaccines hoping that some idiot in India will grant them liability free access to the Indian market.



Covid-19 | Indemnity issues hold up U.S. vaccine doses donation to India
Covid-19 | Indemnity issues hold up U.S. vaccine doses donation to India

Suhasini Haidar
NEW DELHI,
JULY 07, 2021



Delay is not from the U.S. side, says an American Embassy spokesperson

More than a month after the United States announced the donation of 80 million doses of American-made COVID vaccines to dozens of countries including India, and Vice-President Kamala Harris called Prime Minister Narendra Modi to convey the decision, the vaccines are being held up by regulatory issues ove r indemnity, Indian and U.S. officials confirmed.

According to the officials, the demand by the U.S. companies including Pfizer, Moderna and Johnson and Johnson to be granted an indemnity or waiver of liability has yet to be resolved for commercial distribution, which is also holding up the donations from the U.S. Since June 3, the U.S. has already distributed 40 million doses to about 12 countries including Pakistan and Bangladesh.

Legal provisions
“The delay is not from the U.S. side,” an American Embassy spokesperson said to queries about the fact that the shipments are yet to be announced. “India has determined that it needs further time to review legal provisions related to accepting vaccine donations. Once India works through its legal process, our donation of vaccines to India will proceed expeditiously.”

The MEA declined to comment on the issue, directing queries to the Ministry of Health. Health Secretary Bharat Bhushan told The Hindu that the “specific provisions of indemnification are still under discussion”, indicating that not only are the U.S. vaccine donations on hold for the moment, but casting a cloud over the delivery of Moderna vaccines, which have already received Emergency Use Authorisation (EUA) in India, of which the first consignment was due to arrive this week.

During his visit to the U.S. in May, External Affairs Minister S. Jaishankar had met pharma company executives and U.S. business chambers who had conveyed concerns about India’s request for them to provide vaccines without receiving indemnity in case of side effects found by those being administered the vaccines. The indemnity would be used as a legal defence to protect the U.S. companies, who have pointed out that they cannot take responsibility for cold-chain lapses and storage and transportation problems within India.

“Yes, liability issues remain unresolved,” confirmed one official involved in the negotiations, adding that the ‘dilemma’ on the Indian side is that if the U.S. companies are given indemnities, all vaccine manufacturers, including Serum Institute, Bharat Biotech and Sputnik would also demand the same flexibility.


India in two baskets
Last month, the U.S. announced the distribution of 80 million doses of American made vaccines as part of its “COVID-19 Global Response and Recovery Framework”. While a specific number of doses was not announced for any country, India was put in two baskets: among 19 Asian countries that would receive 23 million doses and 14 regional partners that would receive an additional 6 million doses in all. Indian officials had estimated at the time that India’s share would total not more than a mere 2 million doses, less than half of its daily dispersal of vaccines, but said the donation was important as it made more types of vaccines available to Indians.

The countries that have received the U.S. donations so far include South Korea, Mexico, Canada, Brazil, Taiwan, Honduras, Colombia, Pakistan, Peru, Ecuador, Malaysia, & Bangladesh. Other nations like Sri Lanka received the first batch of an expected five million doses of Pfizer/BioNTech vaccines that are being funded by the World Bank, while Maldives had earlier received Pfizer vaccines through the international COVAX alliance.

“Before we can ship doses, each country must complete its own domestic set of operational, regulatory, and legal processes that are specific to each country,” the U.S. Embassy spokesperson said, in an explanation of how other countries had received their doses.
vijayk
BRF Oldie
Posts: 8785
Joined: 22 Jun 1999 11:31

Re: Wuhan Coronavirus Resource Thread

Post by vijayk »

48,89,36,423. https://pib.gov.in/PressReleasePage.aspx?PRID=1742476. 04 AUG 2021 8:05PM Wednesday
48,41,81,676 https://pib.gov.in/PressReleasePage.aspx?PRID=1742032. 03 AUG 2021 7PM Tuesday

Total for wednesday 8/4 - 47,54,747

Cumulative first dose = 38,07,92,729

Cumulative second dose = 10,81,43,694
disha
BR Mainsite Crew
Posts: 8243
Joined: 03 Dec 2006 04:17
Location: gaganaviharin

Re: Wuhan Coronavirus Resource Thread

Post by disha »

There is a reason why rNDTV is abhorred on this pages. rNDTV is anti-national. Ppl working for rNDTV are also anti-national by default. They do have choice of working somewhere else.
Amber G. wrote:^^^That was shocking, shameful, and dangerous misreporting by ⁦@SreenivasanJain⁩ This is not Journalism one can trust.
How NDTV’s Sreenivasan Jain played mischief to create panic regarding Covaxin efficacy
And just proves that rNDTV is an extension of US SD. US SD policy is to support US MIC.
disha
BR Mainsite Crew
Posts: 8243
Joined: 03 Dec 2006 04:17
Location: gaganaviharin

Re: Wuhan Coronavirus Resource Thread

Post by disha »

saip wrote:50% of the active cases in India are coming from ONE state - Kerala. They even received and award for management of Covid19. So what happened?
Look at the other way, instead of 100% of the active cases only 50% are coming from Kerala. That is they have contained the active cases by half. That is remarkable isn't it?

Question someone must ask, if 50% of active cases are coming from Kerala and if the case mortality rate is same as India, why the all India mortality figures are to be doubted but not of Kerala?
shaun
BRFite
Posts: 1385
Joined: 11 Aug 2016 06:14

Re: Wuhan Coronavirus Resource Thread

Post by shaun »

Amber G.
BRF Oldie
Posts: 9265
Joined: 17 Dec 2002 12:31
Location: Ohio, USA

Re: Wuhan Coronavirus Resource Thread

Post by Amber G. »

saip wrote:50% of the active cases in India are coming from ONE state - Kerala. They even received and award for management of Covid19. So what happened?
You may like to see my previous post <here>
SUTRA Model seems to fit quite well ..As said:
The containment strategy adopted by the state was a success until February. It managed to keep most of the population away from the pandemic. However, with onset of delta-variant, the strategy has not worked well resulting in spread of pandemic everywhere.

With seropositivity around 52% at present and pandemic spread over nearly entire population, there is a long way to go before herd immunity is reached.
If contact rate is brought down from its current value of 0.33, the numbers will start reducing, however, herd immunity will not be reached and lockdown will have to be kept until a large fraction is vaccinated. (See graph in earlier post)
If strict lockdown is lifted and and people don't go crazy .. the contact rate should settle down around 0.35. The resulting trajectory was shown in my previous post - it shows a peak of around 25K infections by mid August. By September, seropositivity would be 75% and then even without any precautions cases will not rise.
(All assuming new variant which escapes immunity and is contagious does not appear - but then we all are in trouble)

Let us see how well this model turns out - will check in a month.
Kakkaji
BRF Oldie
Posts: 3866
Joined: 23 Oct 2002 11:31

Re: Wuhan Coronavirus Resource Thread

Post by Kakkaji »

Govt likely to reduce private sector's 25% Covid-19 vaccine quota
The Centre has indicated that with lower utilisation of Covid vaccines by the private sector, its 25 per cent quota may not be necessary.

Health minister Mansukh Mandaviya told Rajya Sabha, in response to a question by MP Sushil Kumar Modi, that the government took over 7-9 per cent of the private sector’s quota since it had not been utilised.

Vaccine makers, the government has indicated, can provide doses to the private sector according to demand and the remaining would be bought by the government.

If private players do not pick up 25 per cent of the vaccines produced, manufacturers may face financial losses. The prices of Covishield and Covaxin are Rs 600 per dose and Rs 1,200 per dose, respectively, for the private sector. The Centre procures Covishield at Rs 215 per dose and Covaxin at Rs 225 per dose, inclusive of taxes.

A source in a vaccine manufacturing firm said that the government has indicated that vaccine makers need not compulsorily hold 25 per cent of their monthly production for the private sector, but continue to supply based on orders placed.

“We usually indicate our production plan to the government in advance, which helps it to plan the procurement and distribution. We will continue to do so. The Centre also knows about a consolidated demand from the private sector, as state governments collate the demand from the private sector and indicate this to the Centre,” said an executive.

The person added that if this demand estimation shows that the demand from the private sector is less than 25 per cent of the total volumes, then vaccine makers will supply private hospitals according to orders placed.

This also implies that the Centre can procure more than the 75 per cent quota that it has allocated for government purchase, if the demand from the private sector is less.

Another executive at a vaccine making company said, “The private sector’s vaccination drive is now spreading beyond metros. Demand would be there. Some hospitals had created a stockpile, and are thus ordering according to their consumption pattern,” the executive said.

At least two leading hospitals said they have not yet heard from either the Centre or vaccine makers about any policy change. “We continue to place orders based on our requirements,” said a senior executive.

Private hospitals also feel that with the Centre deciding to increase the free vaccinations to 75 per cent, the number of people willing to pay for a jab has reduced significantly. “Consequently, the private sector has been able to only vaccinate about 7 per cent of the people in May. Government buying all the remaining doses would lead to faster vaccination of the adult population, and hopefully, lead to minimising effects of the third wave,” said Harsh Mahajan, president, Nathealth, a healthcare body.
chetak
BRF Oldie
Posts: 32283
Joined: 16 May 2008 12:00

Re: Wuhan Coronavirus Resource Thread

Post by chetak »

disha wrote:There is a reason why rNDTV is abhorred on this pages. rNDTV is anti-national. Ppl working for rNDTV are also anti-national by default. They do have choice of working somewhere else.
Amber G. wrote:^^^That was shocking, shameful, and dangerous misreporting by ⁦@SreenivasanJain⁩ This is not Journalism one can trust.
How NDTV’s Sreenivasan Jain played mischief to create panic regarding Covaxin efficacy
And just proves that rNDTV is an extension of US SD. US SD policy is to support US MIC.
First tweet something sensational. Get 1000 plus RTs. Mislead people. Add to vaccine hesitancy and once the tweet has reached places, add a disclaimer in the end slimy@SreenivasanJain
Amber G.
BRF Oldie
Posts: 9265
Joined: 17 Dec 2002 12:31
Location: Ohio, USA

Re: Wuhan Coronavirus Resource Thread

Post by Amber G. »

vijayk wrote:48,89,36,423.
Cumulative first dose = 38,07,92,729
Cumulative second dose = 10,81,43,694
Excellent --- Good news is, *even* if we slip in the speed of vaccines, per sutra model, next wave will be a ripple. (Actually in prediction with different scenerios .. not so fast vaccine rates is not that bad .. - see my previous posts). It will be great if we reach our goal, say 1B doses in 3 months but even if it is delayed by a month or two - it will be okay ( IOW even if we take conservative numbers for vaccines - India is doing quite good).

Only thing, no new variant (especially which escapes immunity - natural or vaccine given)..
Will be interesting to revisit this post to see how it panned out.
Mort Walker
BRF Oldie
Posts: 10033
Joined: 31 May 2004 11:31
Location: The rings around Uranus.

Re: Wuhan Coronavirus Resource Thread

Post by Mort Walker »

49,45,58,204 cumulative vaccinations to date. By Saturday, I think, the 50 crore mark will be crossed.

https://www.pib.gov.in/PressReleseDetai ... ID=1742911
vijayk
BRF Oldie
Posts: 8785
Joined: 22 Jun 1999 11:31

Re: Wuhan Coronavirus Resource Thread

Post by vijayk »

Mort Walker wrote:49,45,58,204 cumulative vaccinations to date. By Saturday, I think, the 50 crore mark will be crossed.

https://www.pib.gov.in/PressReleseDetai ... ID=1742911
49,45,58,204 https://www.pib.gov.in/PressReleseDetai ... ID=1742911 8/5 7 PM Thursday
48,89,36,423. https://pib.gov.in/PressReleasePage.aspx?PRID=1742476. 04 AUG 2021 8:05PM Wednesday

Total for Thursday (8/5) - 56,21,781

Cumulative

1st dose 38,49,85,683

2nd Dose 10,95,72,521
Kakkaji
BRF Oldie
Posts: 3866
Joined: 23 Oct 2002 11:31

Re: Wuhan Coronavirus Resource Thread

Post by Kakkaji »

Bharat Biotech is responding to the misinformation spread by presstitutes:

Bharat Biotech’s Gujarat, Karnataka facilities begin Covaxin production
Bharat Biotech on Thursday said that their new plant in Karnataka and their facility in Gujarat had started manufacturing their Covid-19 vaccine — Covaxin. The products manufactured from these facilities would be available for supplies from September.

The government had acknowledged some technical glitches at Bharat Biotech’s new facility at Malur in Karnataka which had delayed production of Covaxin. The company said the Malur and Ankleshwar plant in Gujarat had started production of Covaxin in June and it would take 120 days for manufacturing, testing, release, regulatory approvals and distribution.

The company said all the batches of Covaxin vaccine supplied till date was being manufactured and released only from their manufacturing facilities at Genome Valley Hyderabad, which was audited and approved by regulatory authorities. The company has supplied 70 million doses till date from this facility.

Allaying fears over quality of vaccines from its new plant, the company said vaccinology, vaccine manufacturing, testing, and release was a complex science. Bharat Biotech said they were the only company to develop a vaccine indigenously in India and manufacture it in scale. Covaxin had also demonstrated efficacy against the Delta variant in phase III human clinical trials.

Bharat Biotech said Covaxin had on Thursday received Good Manufacturing Practices (GMP) compliance certificate from the Hungarian authorities. The approval came from the National Institute of Pharmacy and Nutrition, Hungary, which has certified the GMP for the manufacture of Covaxin. The company now intends to submit documentation for emergency use authorisation to several additional countries worldwide. This was the first EudraGMP-compliance certificate received by Bharat Biotech from an European regulatory agency.
Kakkaji
BRF Oldie
Posts: 3866
Joined: 23 Oct 2002 11:31

Re: Wuhan Coronavirus Resource Thread

Post by Kakkaji »

Full statement by Bharat Biotech in this story:

‘Highly purified and safe vaccine’: Bharat Biotech allays concerns over Covaxin’s quality
Read the Full Statement Issued by Bharat Biotech:

“There have been recent articles in social media and media outlets regarding the quality of COVAXIN®️, we hereby wish to set the record straight with the following statements,

• As of date all batches of COVAXIN®️ are manufactured and released only from our manufacturing facilities at Genome Valley Hyderabad, which are fully audited and approved by regulatory authorities, hence we wish to put to rest any concerns on the quality of COVAXIN®️,

• Every batch of COVAXIN®️ is subjected to more than 200 quality control tests at our facilities, followed by submission samples to Central Drugs Laboratory (CDL) Government of India, only based on approval/release by CDL, are batches released commercially,

• Since early June, manufacturing of COVAXIN®️ has commenced at our sites at Malur, Karnataka, and Ankleshwar, Gujarat, prior to which engineering batches were also executed to study equipment functionality. Products manufactured from these facilities will be available for supplies during September. This is based on our 120-day timeline for manufacturing, testing, release, regulatory approvals, and distribution,

• Vaccine manufacturing, testing, and release at Bharat Biotech follow validated, stringent GMP processes which were established over 20 years, with several billion doses of vaccines supplied within India and globally,

• Since vaccines are administered to healthy individuals, safety is always our vital, primary criteria and we have an uncompromising policy on safety, and quality, whatsoever. This is evident from the excellent safety contours of COVAXIN®️ with an impressive supply of ~ 70 million doses to date. It is emblematic that Bharat Biotech has not sought Indemnity from the Government of India for any adverse events from COVAXIN®️,

• The whole-virion Inactivated Vero Cell vaccines (COVAXIN®️ technology platform) are highly complex to manufacture as the critical ingredient is based on live viruses which require highly sophisticated, multiple level containment and purification methods. Such extensive, high standards of purification naturally lead to significant process losses and low yields resulting in a highly purified and safe vaccine,

• The SARS COV2 strains provided under material transfer agreements to Bharat Biotech are also readily available at the ICMR-NIV and is accessible to any organization that wishes to manufacture a similar COVID-19 vaccine,

• Vaccinology, vaccine manufacturing, testing, and release is a complex multifactorial science involving inputs from more than 30 scientific and technological disciplines. This is evident from the fact that since the start of the pandemic only 2 vaccine companies have been able to supply COVID-19 vaccines to the Government of India,

• Bharat biotech is the only company to develop a vaccine indigenously in India and manufacture it large scale. It has accomplished this in a matter of 15 months, with 10 publications and global recognition for India as an innovator and product developer. COVAXIN®️ is the only vaccine to have demonstrated efficacy against the delta variant in phase III human clinical trials,

Fake news and false and misleading narratives result in unintended consequences of creating panic in our population, resulting in vaccine hesitancy, extending our country’s timelines to return to normalcy and restoration of livelihoods. We humbly request media organizations and influencers to use caution, restraint, detailed analysis in their reportage and their external communication.
Clarifying statement by Dr NK Arora (who was misquoted by Sreenivas Jain of NDTV:
Around 47 crore vaccine doses administered in July and second half of June. Vaccine availability will increase quite significantly in August & overall. Bharat Biotech is expected to provide 7-10 crore doses per month in the coming weeks: Dr NK Arora, Chairman, COVID working group pic.twitter.com/BF5ZTPJG12

— ANI (@ANI) August 2, 2021
vera_k
BRF Oldie
Posts: 3986
Joined: 20 Nov 2006 13:45

Re: Wuhan Coronavirus Resource Thread

Post by vera_k »

FDA Covid-19 Vaccine Booster Plan Could Be Ready Within Weeks
Recent data from Pfizer Inc. and BioNTech SE shows the efficacy of their shot declines about 6% every two months, which suggests boosters may be needed broadly
Amber G.
BRF Oldie
Posts: 9265
Joined: 17 Dec 2002 12:31
Location: Ohio, USA

Re: Wuhan Coronavirus Resource Thread

Post by Amber G. »

India’s COVID-19 Vaccination Coverage crosses landmark milestone - 50 Cr
(August 6, 2021)


(500,348,866), as per the 7 pm provisional report today.
About 5.8 Million (5.790) in last 24 Hours. (About 4.32 Million today till 7 PM)
1st dose: 389,475,520
2nd dose: 110,873,346
So we have Nearly 400 Million people with at least one dose!
Last edited by Amber G. on 07 Aug 2021 18:44, edited 2 times in total.
vijayk
BRF Oldie
Posts: 8785
Joined: 22 Jun 1999 11:31

Re: Wuhan Coronavirus Resource Thread

Post by vijayk »

Amber G. wrote:India’s COVID-19 Vaccination Coverage crosses landmark milestone - 50 Cr
(August 6, 2021)


(500,348,866), as per the 7 pm provisional report today.
About 5.8 Million (5.790) in last 24 Hours. (About 4.32 Million today till 7 PM)
1st dose: 389,475,520
2nd dose: 110,873,346
So we have More that 400 Million people with at least one dose!
:D :D
Kakkaji
BRF Oldie
Posts: 3866
Joined: 23 Oct 2002 11:31

Re: Wuhan Coronavirus Resource Thread

Post by Kakkaji »

Monthly production capacity of Covishield, Covaxin planned to be increased: Govt
The monthly vaccine production capacity of Covishield is planned to be increased from 11 crore doses to more than 12 crore doses per month and of Covaxin from 2.5 crore doses to around 5.8 crore, the Lok Sabha was informed on Friday. From January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by Bharat Biotech for the National COVID-19 Vaccination Programme, Minister of State for Health Bharati Pravin Pawar said in a written reply.
vijayk
BRF Oldie
Posts: 8785
Joined: 22 Jun 1999 11:31

Re: Wuhan Coronavirus Resource Thread

Post by vijayk »

Image
sanjaykumar
BRF Oldie
Posts: 6095
Joined: 16 Oct 2005 05:51

Re: Wuhan Coronavirus Resource Thread

Post by sanjaykumar »

What is the at risk age breakdown of the Indian population? 400 million may just be sufficient to attenuate the third wave.
Manish_P
BRF Oldie
Posts: 5414
Joined: 25 Mar 2010 17:34

Re: Wuhan Coronavirus Resource Thread

Post by Manish_P »

Need to factor in the requirement of repeat vaccinations on say a yearly basis.. or might need vaccination twice a year to prevent severe illness..

Pfizer's CEO says Covid vaccine effectiveness drops to 84% after six months
The efficacy of Pfizer's coronavirus vaccine steadily declines to about 84% about six months after a second dose, according to CEO Albert Bourla.

Data from Israel shows the waning immunity also erodes protection from severe illness.
shaun
BRFite
Posts: 1385
Joined: 11 Aug 2016 06:14

Re: Wuhan Coronavirus Resource Thread

Post by shaun »

vijayk wrote:
Amber G. wrote:India’s COVID-19 Vaccination Coverage crosses landmark milestone - 50 Cr
(August 6, 2021)


(500,348,866), as per the 7 pm provisional report today.
About 5.8 Million (5.790) in last 24 Hours. (About 4.32 Million today till 7 PM)
1st dose: 389,475,520
2nd dose: 110,873,346
So we have More that 400 Million people with at least one dose!
:D :D
Good we also know the demography in a very accurate way
Raja
BRFite
Posts: 342
Joined: 01 Jan 1970 05:30

Re: Wuhan Coronavirus Resource Thread

Post by Raja »

err shouldn't it be 2-3 more days before we cross 400 million for people with at least one dose?
Post Reply